“That’s No Longer Tolerated”: Policing Patients’ Use of Non-opioid Substances in Methadone Maintenance Treatment

References

• Australian Injecting & Illicit Drug Users Union (AVIL). (2012). ‘New recovery’, harm reduction & drug use policy statement.
   Google Scholar
• Avants, S. K., A. Margolin, M. H. Usubiaga, and C. Doebrick. 2004. Targeting HIV-related outcomes with intravenous drug users maintained on methadone: A randomized clinical trial of a harm reduction group therapy. Journal of Substance Abuse Treatment 26 (2):67–78. doi:10.1016/S0740-5472(03)00159-4.
   PubMed Web of Science ®Google Scholar
• Bourgois, P. 2000. Disciplining addictions: The bio-politics of methadone and heroin in the United States. Culture, Medicine and Psychiatry 24 (2):165–95. doi:10.1023/A:1005574918294.
   PubMed Web of Science ®Google Scholar
• Bruce, R. D. 2010. Methadone as HIV prevention: High volume methadone sites to decrease HIV incidence rates in resource limited settings. International Journal of Drug Policy 21 (2):122–24. doi:10.1016/j.drugpo.2009.10.004.
   PubMed Web of Science ®Google Scholar
• Brugal, M. T., A. Domingo‐Salvany, R. Puig, G. Barrio, P. Garcia de Olalla, and L. De La Fuente. 2005. Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain. Addiction 100 (7):981–89. doi:10.1111/j.1360-0443.2005.01089.x.
   PubMed Web of Science ®Google Scholar
• Calley Jones, C. 2010. Playing at the queer edges. Leisure Studies 29 (3):269–87. doi:10.1080/02614360903401935.
   Web of Science ®Google Scholar
• Cousins, G., C. Teljeur, N. Motterlini, C. McCowan, B. D. Dimitrov, and T. Fahey. 2011. Risk of drug-related mortality during periods of transition in methadone maintenance treatment: A cohort study. Journal of Substance Abuse Treatment 41 (3):252–60. doi:10.1016/j.jsat.2011.05.001.
   PubMed Web of Science ®Google Scholar
• Degenhardt, L., D. Randall, W. Hall, M. Law, T. Butler, and L. Burns. 2009. Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: Risk factors and lives saved. Drug and Alcohol Dependence 105 (1–2):9–15. doi:10.1016/j.drugalcdep.2009.05.021.
   PubMed Web of Science ®Google Scholar
• Ekendahl, M. 2011. The limits of legitimacy: Service providers’ views on maintenance treatment in Sweden. Addiction Research & Theory 19 (5):427–37. doi:10.3109/16066359.2010.545158.
   Web of Science ®Google Scholar
• Ellis, C., T. E. Adams, and A. P. Bochner. 2011. Autoethnography: An overview. Historical Social research/Historische Sozialforschung 36 (4):273–90.
   Web of Science ®Google Scholar
• Farrell-MacDonald, S., M. A. MacSwain, M. Cheverie, M. Tiesmaki, and B. Fischer. 2014. Impact of methadone maintenance treatment on women offenders’ post-release recidivism. European Addiction Research 20 (4):192–99. doi:10.1159/000357942.
   PubMed Web of Science ®Google Scholar
• Frank, D. 2018. “I was not sick and i didn’t need to recover”: Methadone maintenance treatment (MMT) as a refuge from criminalization. Substance Use & Misuse 53 (2):311–22. doi:10.1080/10826084.2017.1310247.
   PubMed Web of Science ®Google Scholar
• Frank, D. 2019. ‘We’re gonna be addressing your Pepsi use’: How recovery limits methadone maintenance treatment’s ability to help people in the era of overdose. Journal of Extreme Anthropology 3 (2):1–20. doi:10.5617/jea.6737.
   Google Scholar
• Fraser, S., D. Moore, and H. Keane. 2014. Habits: Remaking addiction. Springer.
   Google Scholar
• Fraser, S., and K. Valentine. 2008. Substance and substitution: Methadone subjects in liberal societies. Springer.
   Google Scholar
• Frost, N., and F. Elichaoff. 2014. Feminist postmodernism, poststructuralism, and critical theory. Feminist Research Practice: A Primer 42–72.
   Google Scholar
• Gerra, G., E. Saenz, A. Busse, I. Maremmani, R. Ciccocioppo, A. Zaimovic, M. L. Gerra, M. Amore, M. Manfredini, C. Donnini, et al. 2011. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance. Progress in Neuro-Psychopharmacology and Biological Psychiatry 35 (2):483–89. doi:10.1016/j.pnpbp.2010.12.002.
   PubMed Web of Science ®Google Scholar
• Harris, M., and T. Rhodes. 2013. Methadone diversion as a protective strategy: The harm reduction potential of ‘generous constraints’. International Journal of Drug Policy 24 (6):e43–e50. doi:10.1016/j.drugpo.2012.10.003.
   PubMedGoogle Scholar
• International Network of People who Use Drugs (INPUD). (2020). INPUD position statement on language, identity, inclusivity and discrimination; Draft version 2.1. Accessed June 24, 2020. https://inpud.wordpress.com/position-papers/inpud-position-statement-on-language-identity-inclusivity-and-discrimination/
   Google Scholar
• International Network of People Who Use Drugs (INPUD). (2020b). Accessed April 23, 2020. https://idpc.net/profile/international-network-of-people-who-use-drugs-inpud
   Google Scholar
• Järvinen, M. 2008. Approaches to methadone treatment: Harm reduction in theory and practice. Sociology of Health & Illness 30 (7):975–91. doi:10.1111/j.1467-9566.2008.01094.x.
   PubMed Web of Science ®Google Scholar
• Joseph, H., S. Stancliff, and J. Langrod. 2000. Methadone maintenance treatment (MMT). The Mount Sinai Journal of Medicine 67 (5):6.
   PubMedGoogle Scholar
• Karki, P., R. Shrestha, T. B. Huedo-Medina, and M. Copenhaver. 2016. The impact of methadone maintenance treatment on HIV risk behaviors among high-risk injection drug users: A systematic review. Evidence-based Medicine & Public Health 2.
   Google Scholar
• Keane, H. 2002. What’s wrong with addiction? Melbourne University Publish.
   Google Scholar
• Koester, S., K. Anderson, and L. Hoffer. 1999. Active heroin injectors’ perceptions and use of methadone maintenance treatment: Cynical performance or self-prescribed risk reduction? Substance Use & Misuse 34 (14):2135–53. doi:10.3109/10826089909039442.
   PubMed Web of Science ®Google Scholar
• Le, T. A., D. T. Pham, T. T. Quek, G. T. Vu, C. L. Hoang, T. T. Tran, … B. X. Tran. 2019. Polysubstance use among patients enrolling in methadone maintenance treatment program in a Vietnam province with drug-driven HIV epidemic. International Journal of Environmental Research and Public Health 16 (18):3277. doi:10.3390/ijerph16183277.
   PubMed Web of Science ®Google Scholar
• Lilly, A. Q., G. V. Tim Rhodes, and R. Stimson. 2000. Sociality in methadone treatment: Understanding methadone treatment and service delivery as a social process. Drugs: Education, Prevention and Policy 7 (2):163–78.
   Web of Science ®Google Scholar
• Magura, S., and A. Rosenblum. 2001. Leaving methadone treatment: Lessons learned, lessons forgotten, lessons ignored. The Mount Sinai Journal of Medicine, New York 68 (1):62–74.
   PubMed Web of Science ®Google Scholar
• Mateu-Gelabert, P., M. Sandoval, P. Meylakhs, T. Wendel, and S. R. Friedman. 2010. Strategies to avoid opiate withdrawal: Implications for HCV and HIV risks. International Journal of Drug Policy 21 (3):179–85. doi:10.1016/j.drugpo.2009.08.007.
   PubMed Web of Science ®Google Scholar
• McBrien, H., C. Luo, N. Sanger, L. Zielinski, M. Bhatt, X. M. Zhu, D. C. Marsh, L. Thabane, and Z. Samaan. 2019. Cannabis use during methadone maintenance treatment for opioid use disorder: A systematic review and meta-analysis. CMAJ Open 7 (4):E665–E673. doi:10.9778/cmajo.20190026.
   PubMedGoogle Scholar
• Millson, P., L. Challacombe, P. J. Villeneuve, C. J. Strike, B. Fischer, T. Myers, R. Shore, and S. Hopkins. 2007. Reduction in injection–related HIV risk after 6 months in a low-threshold methadone treatment program. AIDS Education & Prevention 19 (2):124–36. doi:10.1521/aeap.2007.19.2.124.
   PubMed Web of Science ®Google Scholar
• Netherland, J. 2012. Introduction: Sociology and the shifting landscape of addiction. In Critical perspectives on addiction, xi–xxv. Bingley, UK: Emerald Group Publishing Limited.
   Google Scholar
• Nolan, S., K. Hayashi, M. J. Milloy, T. Kerr, H. Dong, V. D. Lima, L. Lappalainen, J. Montaner, and E. Wood. 2015. The impact of low-threshold methadone maintenance treatment on mortality in a Canadian setting. Drug and Alcohol Dependence 156:57–61.
   PubMed Web of Science ®Google Scholar
• O’Byrne, P., and C. Jeske Pearson. 2019. Methadone maintenance treatment as social control: Analyzing patient experiences. Nursing Inquiry 26 (2):e12275. doi:10.1111/nin.12275.
   PubMed Web of Science ®Google Scholar
• Pani, P. P., R. Pirastu, A. Ricci, and G. L. Gessa. 1996. Prohibition of take-home dosages: Negative consequences on methadone maintenance treatment. Drug and Alcohol Dependence 41 (1):81–84. doi:10.1016/0376-8716(96)01240-9.
   PubMed Web of Science ®Google Scholar
• Peles, E., S. Linzy, M. Kreek, and M. Adelson. 2008. One-year and cumulative retention as predictors of success in methadone maintenance treatment: A comparison of two clinics in the United States and Israel. Journal of Addictive Diseases 27 (4):11–25. doi:10.1080/10550880802324382.
   PubMed Web of Science ®Google Scholar
• Peterson, J. A., R. P. Schwartz, S. G. Mitchell, H. S. Reisinger, S. M. Kelly, K. E. O’Grady, B. S. Brown, and M. H. Agar. 2010. Why don’t out-of-treatment individuals enter methadone treatment programmes? International Journal of Drug Policy 21 (1):36–42. doi:10.1016/j.drugpo.2008.07.004.
   PubMed Web of Science ®Google Scholar
• Rooney, P. 2005. Researching from the inside, does it compromise validity: A discussion. Level 3 3 (1):4.
   Google Scholar
• Saloner, B., and S. Karthikeyan. 2015. Changes in substance abuse treatment use among individuals with opioid use disorders in the United States, 2004–2013. Jama 314 (14):1515–17. doi:10.1001/jama.2015.10345.
   PubMed Web of Science ®Google Scholar
• Scavone, J. L., R. C. Sterling, S. P. Weinstein, and E. J. Van Bockstaele. 2013. Impact of cannabis use during stabilization on methadone maintenance treatment. The American Journal on Addictions 22 (4):344–51. doi:10.1111/j.1521-0391.2013.12044.x.
   PubMed Web of Science ®Google Scholar
• Scholl, L., P. Seth, M. Kariisa, N. Wilson, and G. Baldwin. 2019. Drug and opioid-involved overdose deaths—United States, 2013–2017. Morbidity and Mortality Weekly Report 67 (5152):1419.
   Google Scholar
• Schwartz, R. P., J. Gryczynski, K. E. O’Grady, J. M. Sharfstein, G. Warren, Y. Olsen, S. G. Mitchell, and J. H. Jaffe. 2013. Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995–2009. American Journal of Public Health 103 (5):917–22. doi:10.2105/AJPH.2012.301049.
   PubMed Web of Science ®Google Scholar
• Sordo, L., G. Barrio, M. J. Bravo, B. I. Indave, L. Degenhardt, L. Wiessing, M. Ferri, and R. Pastor-Barriuso. 2017. Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies. BMJ 357:j1550.
   PubMed Web of Science ®Google Scholar
• Strike, C., M. Millson, S. Hopkins, and C. Smith. 2013. What is low threshold methadone maintenance treatment? International Journal of Drug Policy 24 (6):e51–e56. doi:10.1016/j.drugpo.2013.05.005.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Service Administration. (2014). ‘Treatment episode data set. 2014ʹ. Accessed February 16, 2020. https://www.samhsa.gov/data/sites/default/files/2014_TEDS_Discharge.pdf
   Google Scholar
• Substance Abuse and Mental Health Services Administration. (2019b). Recovery and recovery support. Accessed November 1, 2018. https://www.samhsa.gov/find-help/recovery
   Google Scholar
• Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. 2019a. Treatment episode data set (TEDS): 2017. Admissions to and discharges from publicly-funded substance use treatment. Rockville, MD: Substance Abuse and Mental Health Services Administration.
   Google Scholar
• Van Hout, M. C., and T. Bingham. 2014. A qualitative study of prescribing doctor experiences of methadone maintenance treatment. International Journal of Mental Health and Addiction 12 (3):227–42. doi:10.1007/s11469-013-9436-3.
   Web of Science ®Google Scholar
• White, W. L., and L. Mojer-Torres. 2010. Recovery-oriented methadone maintenance. Chicago, IL: Great Lakes Addiction Technology Transfer Center.
   Google Scholar